Alongside the settlement, Novo and Viatris have asked the U.S. Patent and Trademark Office to terminate its review of the ...

L&T's R Shankar Raman has projected the EPC major's current $60 billion orderbook to rise by four-fold in the next 25 years, ...

Ahead of the market opening on Wednesday, Axis Direct picked five stocks that can generate profits in 5 to 15 days. These are ...

Novo Nordisk (NOV: N) has reached a settlement with Mylan Pharmaceuticals, part of Viatris (Nasdaq: VTRS), concluding a US ...

IST, the barometer index, the S&P BSE Sensex was up 396.50 points or 0.49% to 81,446.50. The Nifty 50 index added 136.05 points or 0.55% to 24,931.80.

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

Shares of Tata Power and JSW Energy rose after Nomura initiated coverage, recommending 'buy' ratings with target prices of Rs ...

Gilead Sciences collaborates with Indian companies to produce affordable generic versions of its HIV prevention therapy, ...

In view of the Supreme Court's "long conference" on September 30th, it seems timely to review the arguments, pro, con, ...

Natco Pharma shares rise 3% as partner Mylan settles U.S. patent litigation with Novo Nordisk for generic Ozempic.